Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies

Two 1-year studies evaluated the long-term efficacy and safety of tiotropium 5 or 10 μg versus placebo, inhaled via the Respimat(®) Soft Mist™ Inhaler (SMI). The two studies were combined and had 4 co-primary endpoints (trough FEV(1) response, Mahler Transition Dyspnea Index [TDI] and St George’s Re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bateman, Eric, Singh, Dave, Smith, David, Disse, Bernd, Towse, Lesley, Massey, Dan, Blatchford, Jon, Pavia, Demetri, Hodder, Rick
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2010
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921687/
https://ncbi.nlm.nih.gov/pubmed/20714373
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi